PLX·74365A309·US·equity·Healthcare - Biotechnology-13D/G
PLX (PROTALIX BIOTHERAPEUTICS INC) is held by 62 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($7.8M), RENAISSANCE TECHNOLOGIES LLC ($2.7M), STATE STREET CORP ($2.1M). Net institutional sentiment: Mixed.
See how PLX's score breaks down across 4 SEC sources
Showing 1-20 of 67
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer